J Korean Ophthalmol Soc.  2000 Oct;41(10):2044-2050.

The Expression of IL-1 and TNF-alpham RNA in Alkali-burned Cornea in Rabbits

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Gyeongsang National University, #92 Chilam-dong, Chinju, Gyeongsangnamdo, 660-280, Korea.

Abstract

This study investigated the cytokines (IL-1alpha, IL-1beta, IL-1RA, TNF-alpha) mRNA expression in the early inflammatory process of alkali burned rabbit corneas. To create alkali burns, each 4 cornea of New Zealand White rabbits were exposed to filtering paper (5 mm diameter) treated with 1N NaOH for 1 minute at room temperature.e. Two unburned rabbits corneas were used as control. The mRNA levels for IL-1alpha, IL-1beta, IL-1RA, and TNF-alpha were monitored in corneas at 3, 6, 24, and 48 hours after alkali burn with semiquantative reverse transcription-polymerase chain reaction. Transcripts for IL-1alpha, IL-1beta, and TNF-alphawere expressed in 3 hours and increased through 48 hours, whereas those for IL-1betawas expressed in 3 hours and was not changed through 48 hours. IL-1alphamRNA level was detected lower than IL-1betamRNA in 3 hours but IL-1alphamRNA level was persist higher than IL-1betafrom 6 hours through 48 hours. IL-1RA mRNA level was expressed higher than others through 48 hours. These results indicate that IL-1 and TNF-alphalevel in the cornea are elevated during the early inflammatory process of alkali burn. IL-1alpha, IL-RA and TNF-alphamay play an important role in alkali-burned corneal inflammatory process.

Keyword

IL-1; TNF-alpha; Reverse transcription-polymerase chain reaction

MeSH Terms

Alkalies
Burns
Cornea*
Cytokines
Interleukin 1 Receptor Antagonist Protein
Interleukin-1*
Rabbits*
RNA*
RNA, Messenger
Tumor Necrosis Factor-alpha
Alkalies
Cytokines
Interleukin 1 Receptor Antagonist Protein
Interleukin-1
RNA
RNA, Messenger
Tumor Necrosis Factor-alpha
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr